Login / Signup

Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis.

Xiaoli NiuVictoria DivinoSanjay SharmaMitch DekovenVamshi Ruthwik AnupindiCarole Dembek
Published in: Journal of medical economics (2021)
Among patients initiating GLY in a real-world setting, COPD medications, hospitalizations, other HRU, and exacerbations decreased after treatment initiation compared with the 6-month pre-index period.
Keyphrases
  • chronic obstructive pulmonary disease
  • data analysis
  • healthcare
  • cystic fibrosis
  • lung function